Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-1-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1077-9450
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
462-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8970475-Adult,
pubmed-meshheading:8970475-Aged,
pubmed-meshheading:8970475-Antiviral Agents,
pubmed-meshheading:8970475-Female,
pubmed-meshheading:8970475-HIV Seropositivity,
pubmed-meshheading:8970475-Humans,
pubmed-meshheading:8970475-Hydroxyurea,
pubmed-meshheading:8970475-Male,
pubmed-meshheading:8970475-Middle Aged
|
pubmed:year |
1996
|
pubmed:articleTitle |
Hydroxyurea treatment in HIV-infected patients.
|
pubmed:publicationType |
Letter,
Research Support, Non-U.S. Gov't
|